Refeyn, developer of pioneering mass photometry technology, expands its global adoption across contract research organizations (CROs) and contract development and manufacturing organizations (CDMOs).
To continue reading click here
Leading CROs and CDMOs turn to mass photometry for rapid protein, mRNA and viral vector analytics
